At the time of writing, Insmed Inc [INSM] stock is trading at $68.29, down -0.93%. An important factor to consider is whether the stock is rising or falling in short-term value. The INSM shares have gain 2.51% over the last week, with a monthly amount drifted -7.96%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Insmed Inc [NASDAQ: INSM] stock has seen the most recent analyst activity on April 23, 2024, when Truist initiated its Buy rating and assigned the stock a price target of $48. Previously, Wolfe Research started tracking the stock with Outperform rating on February 15, 2024, and set its price target to $42. On December 08, 2023, Wells Fargo initiated with a Overweight rating and assigned a price target of $55 on the stock. Guggenheim initiated its recommendation with a Buy and recommended $50 as its price target on July 26, 2023. Mizuho started tracking with a Buy rating for this stock on December 09, 2022, and assigned it a price target of $28. In a note dated December 07, 2022, Barclays initiated an Overweight rating and provided a target price of $37 on this stock.
For the past year, the stock price of Insmed Inc fluctuated between $21.92 and $80.53. Currently, Wall Street analysts expect the stock to reach $88.5 within the next 12 months. Insmed Inc [NASDAQ: INSM] shares were valued at $68.29 at the most recent close of the market. An investor can expect a potential return of 29.59% based on the average INSM price forecast.
Analyzing the INSM fundamentals
According to Insmed Inc [NASDAQ:INSM], the company’s sales were 342.96M for trailing twelve months, which represents an 18.15% jump. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at -2.14%, Pretax Profit Margin comes in at -2.51%, and Net Profit Margin reading is -2.52%. To continue investigating profitability, this company’s Return on Assets is posted at -0.42, Equity is 12.59 and Total Capital is -0.41. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 2.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 67.05 points at the first support level, and at 65.82 for the second support level. However, for the 1st resistance point, the stock is sitting at 69.87, and for the 2nd resistance point, it is at 71.46.
Ratios To Look Out For
It is important to note that Insmed Inc [NASDAQ:INSM] has a current ratio of 6.37. On the other hand, the Quick Ratio is 5.99, and the Cash Ratio is 1.78. Considering the valuation of this stock, the price to sales ratio is 35.62, the price to book ratio is 25.26.
Transactions by insiders
Recent insider trading involved Flammer Martina M.D., Chief Medical Officer, that happened on Jan 10 ’25 when 6172.0 shares were sold. Chief Medical Officer, Flammer Martina M.D. completed a deal on Jan 07 ’25 to sell 3344.0 shares. Meanwhile, Chief Medical Officer Flammer Martina M.D. sold 1702.0 shares on Jan 08 ’25.
